Pharma Stocks Still a Bargain
Despite the strong performance of health-care stocks in the second quarter, there are still plenty of good buying opportunities in the sector, according to Morningstar's Damien Conover.
Jeremy Glaser: For Morningstar, I'm Jeremy Glaser. The health-care sector was the best performer in the second quarter of 2011 after a few quarters of underperformance.
Here today is Damien Conover, the associate director of Morningstar's health-care team to talk a little bit about why pharma stocks did so well during the last three months and what he expects in the future?
Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.